331 related articles for article (PubMed ID: 8503554)
21. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.
Lipworth BJ; Dempsey OJ; Aziz I
Chest; 2000 Aug; 118(2):321-8. PubMed ID: 10936119
[TBL] [Abstract][Full Text] [Related]
22. Long-term circadian effects of salmeterol in asthmatic children treated with inhaled corticosteroids.
Meijer GG; Postma DS; Mulder PG; van Aalderen WM
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1887-92. PubMed ID: 8520751
[TBL] [Abstract][Full Text] [Related]
23. Formoterol compared with beclomethasone and placebo on allergen-induced asthmatic responses.
Wong BJ; Dolovich J; Ramsdale EH; O'Byrne P; Gontovnick L; Denburg JA; Hargreave FE
Am Rev Respir Dis; 1992 Nov; 146(5 Pt 1):1156-60. PubMed ID: 1443864
[TBL] [Abstract][Full Text] [Related]
24. Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study.
Cazzola M; Matera MG; Santangelo G; Vinciguerra A; Rossi F; D'Amato G
Respir Med; 1995 May; 89(5):357-62. PubMed ID: 7638371
[TBL] [Abstract][Full Text] [Related]
25. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction.
Inman MD; O'Byrne PM
Am J Respir Crit Care Med; 1996 Jan; 153(1):65-9. PubMed ID: 8542164
[TBL] [Abstract][Full Text] [Related]
26. Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction.
Politiek MJ; Boorsma M; Aalbers R
Eur Respir J; 1999 May; 13(5):988-92. PubMed ID: 10414394
[TBL] [Abstract][Full Text] [Related]
27. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
[TBL] [Abstract][Full Text] [Related]
28. Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic children.
Verberne AA; Hop WC; Bos AB; Kerrebijn KF
J Allergy Clin Immunol; 1993 Jan; 91(1 Pt 1):127-34. PubMed ID: 8093705
[TBL] [Abstract][Full Text] [Related]
29. Preventive effects of inhaled formoterol and salbutamol on histamine-induced bronchoconstriction--a placebo-controlled study.
Sovijärvi AR; Reinikainen K; Freudenthal Y; Andersson P; Riska H
Respiration; 1992; 59(5):279-82. PubMed ID: 1488561
[TBL] [Abstract][Full Text] [Related]
30. Sustained protection against distilled water provocation by a single dose of salmeterol in patients with asthma.
Bootsma GP; Dekhuijzen PN; Festen J; Lammers JW; Mulder PG; van Herwaarden CL
Eur Respir J; 1997 Oct; 10(10):2230-6. PubMed ID: 9387945
[TBL] [Abstract][Full Text] [Related]
31. Inhaled steroid/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients.
Lötvall J; Langley S; Woodcock A
Respir Res; 2006 Aug; 7(1):110. PubMed ID: 16919161
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma.
Bjermer L; Rosenborg J; Bengtsson T; Lötvall J
Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810
[TBL] [Abstract][Full Text] [Related]
33. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients.
Lötvall J; Ankerst J
Respir Med; 2008 Mar; 102(3):449-56. PubMed ID: 18023335
[TBL] [Abstract][Full Text] [Related]
34. Salmeterol in exercise-induced bronchoconstriction in asthmatic children: comparison of two doses.
de Benedictis FM; Tuteri G; Pazzelli P; Niccoli A; Mezzetti D; Vaccaro R
Eur Respir J; 1996 Oct; 9(10):2099-103. PubMed ID: 8902473
[TBL] [Abstract][Full Text] [Related]
35. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients.
Taylor DA; Jensen MW; Kanabar V; Engelstätter R; Steinijans VW; Barnes PJ; O'Connor BJ
Am J Respir Crit Care Med; 1999 Jul; 160(1):237-43. PubMed ID: 10390406
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the anti-bronchoconstrictor activities of inhaled formoterol, its (R,R)- and (S,S)-enantiomers and salmeterol in the rhesus monkey.
Fozard JR; Buescher H
Pulm Pharmacol Ther; 2001; 14(4):289-95. PubMed ID: 11440557
[TBL] [Abstract][Full Text] [Related]
37. Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma.
Kozlik-Feldmann R; von Berg A; Berdel D; Reinhardt D
Eur J Med Res; 1996 Jul; 1(10):465-70. PubMed ID: 9438143
[TBL] [Abstract][Full Text] [Related]
38. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
Grove A; Lipworth BJ
Thorax; 1996 Jun; 51(6):585-9. PubMed ID: 8693438
[TBL] [Abstract][Full Text] [Related]
39. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
[TBL] [Abstract][Full Text] [Related]
40. A study with cumulative doses of formoterol and salbutamol in children with asthma.
Foucard T; Lönnerholm G
Eur Respir J; 1991 Nov; 4(10):1174-7. PubMed ID: 1687130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]